NO831950L - Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling - Google Patents

Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling

Info

Publication number
NO831950L
NO831950L NO831950A NO831950A NO831950L NO 831950 L NO831950 L NO 831950L NO 831950 A NO831950 A NO 831950A NO 831950 A NO831950 A NO 831950A NO 831950 L NO831950 L NO 831950L
Authority
NO
Norway
Prior art keywords
compounds
hydrogen
formula
benzyl
cyanidan
Prior art date
Application number
NO831950A
Other languages
English (en)
Norwegian (no)
Inventor
Marc Ernest Ballenegger
Christian Gerard Rimbault
Alban Imre Albert
Andre Jean Weith
Pierre Courbat
Robert Graham Tyson
Derek Reginald Palmer
David George Thompson
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of NO831950L publication Critical patent/NO831950L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
NO831950A 1982-06-01 1983-05-31 Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling NO831950L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8215867 1982-06-01

Publications (1)

Publication Number Publication Date
NO831950L true NO831950L (no) 1983-12-02

Family

ID=10530750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831950A NO831950L (no) 1982-06-01 1983-05-31 Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling

Country Status (19)

Country Link
US (1) US4644011A (de)
EP (1) EP0096007B1 (de)
JP (1) JPS58219177A (de)
KR (1) KR840005124A (de)
AT (1) ATE28641T1 (de)
AU (1) AU568301B2 (de)
CA (1) CA1234103A (de)
DD (1) DD210687A5 (de)
DE (1) DE3372764D1 (de)
DK (1) DK245283A (de)
ES (2) ES8507533A1 (de)
FI (1) FI831926A7 (de)
GB (1) GB2122608B (de)
GR (1) GR78346B (de)
IL (1) IL68832A (de)
NO (1) NO831950L (de)
NZ (1) NZ204422A (de)
PT (1) PT76782B (de)
ZA (1) ZA833908B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141745A (en) * 1986-03-27 1992-08-25 The Lubrizol Corporation Nodulation inducing factors
US4743694A (en) * 1986-04-11 1988-05-10 Mercek & Co., Inc. Diastereocontrolled synthesis of 2-amino alcohols
WO1987007835A1 (fr) * 1986-06-21 1987-12-30 Dainippon Ink And Chemicals, Inc. Medicament pour le traitement et la prophylaxie de maladies du rein et du foie
US6207842B1 (en) 1997-10-09 2001-03-27 Mars Incorporated Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
US6156912A (en) * 1999-04-09 2000-12-05 Mars, Incorporated 88, 66, and 68 catechin and epicatechin dimers and methods for their preparation
US7015338B1 (en) 1999-04-15 2006-03-21 Mars Incorporated Synthetic methods for preparing procyanidin oligomers
NL1016815C2 (nl) * 1999-12-15 2002-05-14 Ciba Sc Holding Ag Oximester-fotoinitiatoren.
US6476241B1 (en) * 2000-09-05 2002-11-05 Mars Incorporated Synthesis of 4α-arylepicatechins
US7067679B2 (en) 2002-10-02 2006-06-27 Mars, Inc. Synthesis of dimeric, trimeric, tetrameric pentameric, and higher oligomeric epicatechin-derived procyanidins having 4,8-interflavan linkages and their use to inhibit cancer cell growth through cell cycle arrest
US20070004796A1 (en) * 2005-06-29 2007-01-04 Romanczyk Leo Jr Processes for the preparation of protected-(+)-catechin and (-)-epicatechin monomers, for coupling the protected monomers with an activated, protected epicatechin monomer, and for the preparation of epicatechin-(4B,8)-epicatechin or -catechin dimers and their digallates
CA2796315A1 (en) * 2010-04-12 2011-10-20 Berkem S.A. Stabilised polyphenol derivatives, process for their manufacture, and uses thereof
JP5890846B2 (ja) * 2011-01-27 2016-03-22 スファエラ ファーマ ピーティーイー リミテッド ポリフェノールの新規合成方法
CN106518802B (zh) * 2016-11-17 2018-11-09 山东铂源药业有限公司 一种2-(3-醛基-4-羟基苯基)-4-甲基噻唑-5-甲酸乙酯的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
US4255336A (en) * 1977-11-25 1981-03-10 Ciba-Geigy Corporation Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-01
EP0037800B1 (de) * 1980-04-03 1987-08-12 Zyma SA Verwendung von O-substituierten Derivaten von (+)-Cyanidanol-3 als Verbindungen mit immunomodulatorischen Eigenschaften

Also Published As

Publication number Publication date
FI831926A0 (fi) 1983-05-30
ATE28641T1 (de) 1987-08-15
GB2122608A (en) 1984-01-18
GR78346B (de) 1984-09-26
IL68832A (en) 1988-06-30
IL68832A0 (en) 1983-09-30
DD210687A5 (de) 1984-06-20
FI831926L (fi) 1983-12-02
EP0096007B1 (de) 1987-07-29
DK245283D0 (da) 1983-05-31
ES8704919A1 (es) 1987-04-16
DK245283A (da) 1983-12-02
EP0096007A2 (de) 1983-12-07
US4644011A (en) 1987-02-17
ZA833908B (en) 1984-01-25
CA1234103A (en) 1988-03-15
NZ204422A (en) 1986-09-10
KR840005124A (ko) 1984-11-03
PT76782B (en) 1986-05-20
ES536423A0 (es) 1987-04-16
GB2122608B (en) 1985-10-02
GB8312765D0 (en) 1983-06-15
ES522814A0 (es) 1985-09-16
ES8507533A1 (es) 1985-09-16
AU568301B2 (en) 1987-12-24
PT76782A (en) 1983-06-01
EP0096007A3 (en) 1984-01-04
JPS58219177A (ja) 1983-12-20
FI831926A7 (fi) 1983-12-02
DE3372764D1 (en) 1987-09-03
AU1525583A (en) 1983-12-08

Similar Documents

Publication Publication Date Title
EP2844637B1 (de) Substituierte 3-haloallylamininhibitoren von ssao und verwendungen davon
NO831950L (no) Farmasoeytiske preparater inneholdende (+)-cyanidan-3-ol-derivater, deres anvendelse, nye substituerte (+)-cyanidan-3-ol-derivater og fremgangsmaater til deres fremstilling
EA016360B1 (ru) Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1, фармацевтическая композиция на их основе и их применение
UA43853C2 (uk) Арилалкілпіридазинони, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
US6172099B1 (en) Tricyclic compounds having saturated rings and medicinal compositions containing the same
NO136492B (de)
PT92180B (pt) Processo para a preparacao de novas mevalonolactonas do tipo tienopiridina e de composicoes farmaceuticas que as contem
EP0125195B1 (de) 4'-Flavonkarbonsäuren, Verfahren zu deren Herstellung und ihre therapeutische Verwendung
NO158871B (no) Analogifremgangsmaate for fremstilling av pyridazinderivater.
WO1991016303A1 (en) Cyclic hydroxamic acids and their use
NO148673B (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO169648B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater
Bender et al. Synthesis and biological properties of some novel heterocyclic homoprostanoids
EP1098873B1 (de) Alpha-(2-hydroxyphenyl)nitrone, diese enthaltenden pharmazeutische zubereitungen sowie deren verwendung zur behandlung von entzündungen
SU1452481A3 (ru) Способ получени гетероциклических соединений
EP0032856A1 (de) 2,3-Dihydroimidazo (1,2-b) pyridazin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung
US4510159A (en) (+)-Cyanidan-3-ol derivatives, pharmaceutical preparations that contain such compounds, and the use of the latter to treat liver or venous diseases
JP2002529409A (ja) グルコース及び脂質低下化合物類
EP0180500A1 (de) Thieno- und Furo[2,3-c]pyrrolderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB2145719A (en) Flavene and thioflavene derivatives, processes for their manufacture, pharmaceutical preparations that contain such compounds, and the use of the latter
US3972883A (en) 1,6-Dimethyl-8β-[2' or 3'-pyrroyloxyethyl or substituted pyrroyloxyethyl]-10α-methoxyergolene compounds
WO2025255550A1 (en) Flavone therapeutics
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
NO783529L (no) Nye derivater av tiazolin.
SU1709904A3 (ru) Способ получени производных гидроксамовой кислоты